Expression profiles of MUC mucin core protein in the intrahepatic biliary system: Physiological distribution and pathological significance

Acta Histochemica et Cytochemica

Volumn 38, Issue 5, 2005, Pages 295-303

  Sasaki, Motoko ^a   Ikeda, Hiroko ^a   Nakanuma, Yasuni ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

Author keywords

Biliary epithelial dysplasia; CDX2; Cholangiocarcinoma; Hepatolithiasis; MUC mucin core protein

Indexed keywords

CORE PROTEIN; MUCIN; MUCIN 1; MUCIN 11; MUCIN 12; MUCIN 13; MUCIN 15; MUCIN 16; MUCIN 17; MUCIN 2; MUCIN 3; MUCIN 4; MUCIN 5AC; MUCIN 5B; MUCIN 6; MUCIN 7; MUCIN 8; MUCINOLMUCIN 8; TRANSCRIPTION FACTOR CDX2; UNCLASSIFIED DRUG;

BILE DUCT; BILE DUCT CARCINOMA; BILE DUCT STONE; CARCINOGENESIS; CELL PROTECTION; CLASSIFICATION; DISEASE ASSOCIATION; DYSPLASIA; EPITHELIUM CELL; GEL; GENE EXPRESSION PROFILING; HEPATOBILIARY SYSTEM; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTESTINE METAPLASIA; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; LIVER; LIVER DISEASE; MUCOSA; PERINATAL PERIOD; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; PYLORUS; REVIEW; STOMACH; STONE FORMATION;

EID: 28444453288     PISSN: 00445991     EISSN: 13475800     Source Type: Journal    
DOI: 10.1267/ahc.38.295     Document Type: Review

References (35)

1. Buisine, M. P., Devisme, L., Degand, P., Dieu, M. C., Gosselin, B., Copin, M. C., Aubert, J. P. and Porchet, N. (2000) Developmental mucin gene expression in the gastroduodenal tract and accessory digestive glands. II. Duodenum and liver, gallbladder, and pancreas. J. Histochem. Cytochem. 48; 1667-1676.
2. Crawley, S. C., Gum, J. R., Jr., Hicks, J. W., Pratt, W. S., Aubert, J. P., Swallow, D. M. and Kim, Y. S. (1999) Genomic organization and structure of the 3′ region of human MUC3: alternative splicing predicts membrane-bound and soluble forms of the mucin. Biochem. Biophys. Res. Commun. 263; 728-736.
3. Higashi, M., Yonezawa, S., Ho, J. J., Tanaka, S., Irimura, T., Kim, Y. S. and Sato, E. (1999) Expression of MUC1 and MUC2 mucin antigens in intrahepatic bile duct tumors: its relationship with a new morphological classification of cholangiocarcinoma. Hepatology 30; 1347-1355.
4. Horinouchi, M., Nagata, K., Nakamura, A., Goto, M., Takao, S., Sakamoto, M., Fukushima, N., Miwa, A., Irimura, T., Imai, K., Sato, E. and Yonezawa, S. (2003) Expression of different glycoforms of membrane mucin (MUC1) and secretory mucin (MUC2, MUC5AC and MUC6) in pancreatic neoplasms. Acta Histochem. Cytochem. 36; 443-453.
5. Ishikawa, A., Sasaki, M., Ohira, S., Ohta, T., Oda, K., Nimura, Y., Chen, M. F., Jan, Y. Y., Yeh, T. S. and Nakanuma, Y. (2004) Aberrant expression of CDX2 is closely related to the intestinal metaplasia and MUC2 expression in intraductal papillary neoplasm of the liver in hepatolithiasis. Lab. Invest. 84; 629-638.
6. Kim, Y. S. and Gum, J. R., Jr. (1995) Diversity of mucin genes, structure, function, and expression. Gastroenterology 109; 999-1001.
7. Kim, Y. S., Gum, J. R., Jr., Crawley, S. C., Deng, G. and Ho, J. J. (1999) Mucin gene and antigen expression in biliopancreatic carcinogenesis. Ann. Oncol. 10 Suppl 4; 51-55.
8. Kinami, Y., Noto, K., Miyazaki, I. and Matsubara, F. (1978) A study of hepatolithiasis related to cholangiocarcinoma. Acta Hepatol. Jpn. 19; 578-583 (in Japanese).
9. Komatsu, M., Jepson, S., Arango, M. E., Carothers Carraway, C. A. and Carraway, K. L. (2001) Muc4/sialomucin complex, an intramembrane modulator of ErbB2/HER2/Neu, potentiates primary tumor growth and suppresses apoptosis in a xenotransplanted tumor. Oncogene 20; 461-470.
10. Lazaridis, K. N., Strazzabosco, M. and Larusso, N. F. (2004) The cholangiopathies: disorders of biliary epithelia. Gastroenterology 127; 1565-1577.
11. Longman, R. J., Douthwaite, J., Sylvester, P. A., Poulsom, R., Corfield, A. P., Thomas, M. G. and Wright, N. A. (2000) Coordinated localisation of mucins and trefoil peptides in the ulcer associated cell lineage and the gastrointestinal mucosa. Gut 47; 792-800.
12. Mollenhauer, J., Wiemann, S., Scheurlen, W., Korn, B., Hayashi, Y., Wilgenbus, K. K., von Deimling, A. and Poustka, A. (1997) DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3-26.1 is deleted in malignant brain tumours. Nat. Genet. 17; 32-39.
13. Mollenhauer, J., Herbertz, S., Helmke, B., Kollender, G., Krebs, I., Madsen, J., Holmskov, U., Sorger, K., Schmitt, L., Wiemann, S., Otto, H. F., Grone, H. J. and Poustka, A. (2001) Deleted in malignant brain tumors 1 is a versatile mucin-like molecule likely to play a differential role in digestive tract cancer. Cancer Res. 61; 8880-8886.
14. Nakanuma, Y., Terada, T., Tanaka, Y. and Ohta, G. (1985) Are hepatolithiasis and cholangiocarcinoma aetiologically related? A morphological study of 12 cases of hepatolithiasis. Virchows Arch. A. 406; 45-58.
15. Nakanuma, Y., Yamaguchi, K., Ohta, G. and Terada, T. (1988) Pathologic features of hepatolithiasis in Japan. Hum. Pathol. 19; 1181-1186.
16. Nakanuma, Y. and Sasaki, M. (1989) Expression of blood-group-related antigens in the intrahepatic biliary tree and hepatocytes in normal livers and various hepatobiliary diseases. Hepatology 10; 174-178.
17. Nakayama, F., Soloway, R. and Nakama, T. (1986) Hepatolithiasis in East Asia. Retrospective study. Dig. Dis. Sci. 31; 21-26.
18. Podolsky, D. (1999) Mucosal immunity and inflammation. V. Innate mechanisms of mucosal defense and repair: the best offense is a good defense. Am. J. Physiol. 277; G495-499.
19. Poulsom, R., Begos, D. and Modlin, I. (1996) Molecular aspects of restitution: functions of trefoil peptides. Yale J. Biol. Med. 69; 137-146.
20. Sasaki, M. and Nakanuma, Y. (1994) Expression of mucin core protein of mammary type in primary liver cancer. Hepatology 20; 1192-1197.
21. Sasaki, M., Nakanuma, Y., Terada, T. and Kim, Y. S. (1995) Biliary epithelial expression of MUC1, MUC2, MUC3 and MUC5/6 apomucins during intrahepatic bile duct development and maturation. An immunohistochemical study. Am. J. Pathol. 147; 574-579.
22. Sasaki, M., Nakanuma, Y. and Kim, Y. S. (1996) Characterization of apomucin expression in intrahepatic cholangiocarcinomas and their precursor lesions: an immunohistochemical study. Hepatology 24; 1074-1078.
23. Sasaki, M., Nakanuma, Y. and Kim, Y. S. (1998) Expression of apomucins in the intrahepatic biliary tree in hepatolithiasis differs from that in normal liver and extrahepatic biliary obstruction. Hepatology 27; 54-61.
24. Sasaki, M., Tsuneyama, K. and Nakanuma, Y. (2003) Aberrant expression of trefoil factor family-1 in biliary epithelium in hepatolithiasis and cholangiocarcinoma. Lab. Invest. 83; 1403-1413.
25. Sasaki, M., Huang, S. F., Chen, M. F., Jan, Y. Y., Yeh, T. S., Ishikawa, A., Mollenhauer, J., Poustka, A., Tsuneyama, K., Nimura, Y., Oda, K. and Nakanuma, Y. (2003) Expression of deleted in malignant brain tumor-1 (DMBT1) molecule in biliary epithelium is augmented in hepatolithiasis: possible participation in lithogenesis. Dig. Dis. Sci. 48; 1234-1240.
26. Sasaki, M., Ikeda, H., Ohira, S., Ishikawa, A. and Nakanuma, Y. (2004) Expression of trefoil factor family 1, 2, and 3 peptide is augmented in hepatolithiasis. Peptides 25; 763-770.
27. Shibahara, H., Tamada, S., Goto, M., Oda, K., Nagino, M., Nagasaka, T., Batra, S. K., Hollingsworth, M. A., Imai, K., Nimura, Y. and Yonezawa, S. (2004) Pathologic features of mucin-producing bile duct tumors: two histopathologic categories as counterparts of pancreatic intraductal papillary-mucinous neoplasms. Am. J. Surg. Pathol. 28; 327-338.
28. Terada, T., Nakanuma, Y. and Ohta, G. (1987) Glandular elements around the intrahepatic bile ducts in man: their morphology and distribution in normal livers. Liver 7; 1-8.
29. Tomasetto, C., Masson, R., Linares, J. L., Wendling, C., Lefebvre, O., Chenard, M. P. and Rio, M. C. (2000) pS2/TFF1 interacts directly with the VWFC cysteine-rich domains of mucins. Gastroenterology 118; 70-80.
30. Trotman, B., Ostrow, J. and Soloway, R. (1974) Pigment vs cholesterol cholelithiasis: comparison of stone and bile composition. Am. J. Dig. Dis. 19; 585-590.
31. Vandenhaute, B., Buisine, M. P., Debailleul, V., Clement, B., Moniaux, N., Dieu, M. C., Degand, P., Porchet, N. and Aubert, J. P. (1997) Mucin gene expression in biliary epithelial cells. J. Hepatol. 27; 1057-1066.
32. Van Eyken, P., Sciot, R., Callea, F., Van der Steen, K., Moerman, P. and Desmet, V. J. (1988) The development of the intrahepatic bile ducts in man: a keratin-immunohistochemical study. Hepatology 8; 1586-1595.
33. Wiede, A., Jagla, W., Welte, T., Kohnlein, T., Busk, H. and Hoffmann, W. (1999) Localization of TFF3, a new mucus-associated peptide of the human respiratory tract. Am. J. Respir. Crit. Care Med. 159; 1330-1335.
34. Zen, Y., Harada, K., Sasaki, M., Tsuneyama, K., Katayanagi, K., Yamamoto, Y. and Nakanuma, Y. (2002) Lipopolysaccharide induces overexpression of MUC2 and MUC5AC in cultured biliary epithelial cells: possible key phenomenon of hepatolithiasis. Am. J. Pathol. 161; 1475-1484.
35. Zhou, H., Schaefer, N., Wolff, M. and Fischer, H. P. (2004) Carcinoma of the ampulla of Vater: comparative histologic/immunohistochemical classification and follow-up. Am. J. Surg. Pathol. 28; 875-882.